Baiyingnuo Biotechnology Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 3

Baiyingnuo Biotechnology General Information

Description

Manufacturer of immunotherapy products designed to advance cancer treatment. The company offers antibody drugs, cell therapy research, peptide-based medicines, and diagnostic kits, enabling healthcare providers and pharmaceutical researchers to improve cancer diagnosis and develop innovative therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 201, East Side of D1-3A, Innovation Park
  • Number 666 Gaoxin Avenue, East Lake High-tech Development Zone
  • Wuhan, Hubei 430000
  • China
+86 027
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room 201, East Side of D1-3A, Innovation Park
  • Number 666 Gaoxin Avenue, East Lake High-tech Development Zone
  • Wuhan, Hubei 430000
  • China
+86 027

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baiyingnuo Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 10-Jun-2026 Completed Generating Revenue
3. Secondary Transaction - Private 16-May-2025 Completed Generating Revenue
2. Secondary Transaction - Private 07-Mar-2025 $1.49M Completed Generating Revenue
1. Seed Round 14-Jun-2022 $1.49M $1.49M Completed Startup
To view Baiyingnuo Biotechnology’s complete valuation and funding history, request access »

Baiyingnuo Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hubei Yangtze River Industrial Investment Group Government Minority
Wuhan Innovation Investment Group Venture Capital Minority
Yuanmiao Private Equity Fund Management PE/Buyout Minority
To view Baiyingnuo Biotechnology’s complete investors history, request access »

Baiyingnuo Biotechnology FAQs

  • When was Baiyingnuo Biotechnology founded?

    Baiyingnuo Biotechnology was founded in 2021.

  • Where is Baiyingnuo Biotechnology headquartered?

    Baiyingnuo Biotechnology is headquartered in Wuhan, China.

  • What industry is Baiyingnuo Biotechnology in?

    Baiyingnuo Biotechnology’s primary industry is Drug Discovery.

  • Is Baiyingnuo Biotechnology a private or public company?

    Baiyingnuo Biotechnology is a Private company.

  • What is Baiyingnuo Biotechnology’s current revenue?

    The current revenue for Baiyingnuo Biotechnology is .

  • How much funding has Baiyingnuo Biotechnology raised over time?

    Baiyingnuo Biotechnology has raised $1.49M.

  • Who are Baiyingnuo Biotechnology’s investors?

    Hubei Yangtze River Industrial Investment Group, Wuhan Innovation Investment Group, and Yuanmiao Private Equity Fund Management have invested in Baiyingnuo Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process